Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer

被引：0
|
作者：
Lisa M. C. van Hoogstraten
Calvin C. O. Man
J. Alfred Witjes
Richard P. Meijer
Sasja F. Mulder
Tineke J. Smilde
Theodora M. Ripping
Lambertus A. Kiemeney
Katja K. H. Aben
机构：
[1] Netherlands Comprehensive Cancer Organisation,Radboud Institute for Health Sciences
[2] Radboud University Medical Centre,Department of Urology
[3] Radboud University Medical Centre,Department of Oncological Urology
[4] University Medical Centre Utrecht,Department of Medical Oncology
[5] Radboud University Medical Centre,Department of Medical Oncology
[6] Jeroen Bosch Hospital,undefined
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Bladder carcinoma; Guideline adherence; MIBC; Muscle-invasive bladder cancer; Neoadjuvant chemotherapy; Radical cystectomy; Variation in healthcare;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1837 / 1845
页数：8
相关论文
共 50 条
  • [21] Immune correlates of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Ginwala, Rashida
    Macfarlane, Alexander
    Liu, David
    Alpaugh, R. K.
    Xiu, Joanne
    Gatalica, Zoran
    Korn, W. M.
    Van Allen, Eliezer M.
    Campbell, Kerry S.
    Kutikov, Alexander
    Plimack, Elizabeth
    Abbosh, Philip H.
    CANCER RESEARCH, 2020, 80 (16)
  • [22] Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Miyagi, Hiroko
    Kwenda, Elizabeth
    Ramnaraign, Brian H.
    Chatzkel, Jonathan A.
    Brisbane, Wayne G.
    O'Malley, Padraic
    Crispen, Paul L.
    CANCERS, 2023, 15 (01)
  • [23] Neoadjuvant Chemotherapy: A New Treatment Paradigm for Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    EUROPEAN UROLOGY, 2009, 55 (02) : 303 - 305
  • [24] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: the invisible pink unicorn
    Kan, R. W. M.
    Chan, T. Y.
    Cheng, C. H.
    Li, M. L.
    Lee, K. C.
    Mui, W. H.
    Chu, S. K.
    Man, C. W.
    BJU INTERNATIONAL, 2015, 115 : 8 - 9
  • [25] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [26] Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer
    Gong, Jun
    ONCOLOGY-NEW YORK, 2022, 36 (01): : 30 - 31
  • [27] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy
    Neuzillet, Y.
    PROGRES EN UROLOGIE, 2015, 25 (09): : 555 - 556
  • [28] PLASTICITY IN THE BIOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER
    Seiler, Roland
    Gibb, Ewan A.
    Wang, Natalie Q.
    Oo, Htoo Zarni
    Lam, Hung-Ming
    Takhar, Mandeep
    Erho, Nicholas
    van Kessel, Kim E.
    Winters, Brian
    Douglas, James
    Lopez, Funda Vakar
    Crabb, Simon J.
    van Rhijn, Bas W. G.
    van de Putte, Elisabeth E. Franzen
    Zwarthoff, Ellen C.
    Thalmann, George N.
    Davicioni, Elai
    Boormans, Joost L.
    Dall'Era, Marc
    van der Heijden, Michiel S.
    Wright, Jonathan L.
    Black, Peter C.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E713 - E714
  • [29] Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Krabbe, Laura-Maria
    Westerman, Mary Elizabeth
    Margulis, Vitaly
    Raj, Ganesh
    Sagalowsky, Arthur I.
    Courtney, Kevin Dale
    Arriaga, Yull Edwin
    Lotan, Yair
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Impact of neoadjuvant chemotherapy on therapeutic management of muscle-invasive bladder cancer
    Meyer, V.
    Flechon, A.
    Tartas, S.
    Fassi-Fehri, H.
    Ruffion, A.
    Martin, X.
    Colombel, M.
    PROGRES EN UROLOGIE, 2015, 25 (02): : 83 - 89
12345